Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts

Catheterization Laboratory, Thoraxcenter, University Hospital, Rotterdam-Dijkzigt, The Netherlands.

OBJECTIVES. The purpose of this review is to assess the value and limitations of balloon angioplasty for the treatment of saphenous vein bypass graft obstructions. The potential efficacy of new interventional techniques is discussed. BACKGROUND. Treatment of ischemia due to saphenous vein bypass graft obstructions poses a difficult problem that will be encountered more often as the pool of surgically treated patients continues to accumulate. Reoperation is technically demanding and is associated with high mortality and morbidity rates. Balloon angioplasty may provide a suitable alternative. METHODS. The review proposes a classification of patients with attempted saphenous vein graft angioplasty according to expected early and late outcome based on the data obtained from the relevant published data and personal experience. RESULTS. Angioplasty of a nonocclusive obstruction in a saphenous vein bypass graft has an initial success rate of approximately 90% and is a safe procedure (procedural death rate < 1%, myocardial infarction rate < 4%). The overall average restenosis rate is 42%. Surgical standby is limited and technically difficult. Angioplasty of chronic total occlusions in old grafts is associated with poor initial and long-term results. The long-term clinical results are unfavorable because of the continuing progression of disease in nontreated vein graft segments and native coronary arteries, in addition to the high restenosis rate. New techniques, although promising, have shown neither better initial results nor reduction of restenosis. Stent placement may be useful in longer graft lesions containing friable material. CONCLUSIONS. Patients may be classified into three groups according to expected early and late outcome on the basis of 1) unfavorable graft anatomy, 2) risk of cardiogenic shock in event of acute graft closure, and 3) age of grafts. The three groups are 1) those with an initial high success, low procedural risk and low restenosis rate; 2) those with an initial high success but high procedural risk and moderate to high restenosis rate; and 3) those with a low success, high risk and high restenosis rate. Balloon angioplasty to treat lesions in venous bypass grafts should be considered a palliative procedure, not a long-term solution, for ongoing progression of coronary artery and vein graft disease. The induced high restenosis rate remains a significant problem.

This article has been cited by other articles:

				A. Coolong, D. S. Baim, R. E. Kuntz, A. J. O'Malley, S. Marulkar, D. E. Cutlip, J. J. Popma, and L. Mauri Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients Circulation, February 12, 2008; 117(6): 790 - 797. [Abstract] [Full Text] [PDF]

				N. Suzuki, K. Kozuma, Y. Ueno, K. Nagaoka, H. Kyono, S. Ishikawa, H. Watanabe, N. Yokoyama, S. Takeshita, and T. Isshiki Serial Quantitative Coronary Analyses for the Evaluation of One-Year Change in Saphenous Vein Grafts Ann. Thorac. Surg., February 1, 2008; 85(2): 525 - 529. [Abstract] [Full Text] [PDF]

				S. B. King III, T. Aversano, W. L. Ballard, R. H. Beekman III, M. J. Cowley, S. G. Ellis, D. P. Faxon, E. L. Hannan, J. W. Hirshfeld Jr, A. K. Jacobs, et al. ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures) J. Am. Coll. Cardiol., July 3, 2007; 50(1): 82 - 108. [Full Text] [PDF]

				R. H. Mehta, E. Honeycutt, E. D. Peterson, C. B. Granger, A. R. Halabi, L. K. Shaw, P. K. Smith, R. M. Califf, R. A. Harrington, and M. H. Sketch Jr Impact of Internal Mammary Artery Conduit on Long-term Outcomes After Percutaneous Intervention of Saphenous Vein Graft Circulation, July 4, 2006; 114(1_suppl): I-396 - I-401. [Abstract] [Full Text] [PDF]

				M. Jonas, G. W. Stone, R. Mehran, J. Hermiller, R. Feldman, H. C. Herrmann, D. A. Cox, R. E. Kuntz, J. J. Popma, C. Rogers, et al. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection Eur. Heart J., April 2, 2006; 27(8): 920 - 928. [Abstract] [Full Text] [PDF]

				L. Ge, I. Iakovou, G. M. Sangiorgi, A. Chieffo, G. Melzi, J. Cosgrave, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome J. Am. Coll. Cardiol., April 5, 2005; 45(7): 989 - 994. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J., April 2, 2005; 26(8): 804 - 847. [Full Text] [PDF]

				G. W. Stone, C. Rogers, J. Hermiller, R. Feldman, P. Hall, R. Haber, A. Masud, P. Cambier, R. P. Caputo, M. Turco, et al. Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts Circulation, August 5, 2003; 108(5): 548 - 553. [Abstract] [Full Text] [PDF]

				T M Schiele, E Regar, S Silber, E Eeckhout, D Baumgart, W Wijns, A Colombo, W Rutsch, D Meerkin, A Gershlick, et al. Clinical and angiographic acute and follow up results of intracoronary {beta} brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary {beta} brachytherapy (RENO) Heart, June 1, 2003; 89(6): 640 - 644. [Abstract] [Full Text] [PDF]

				P.J. de Feyter Percutaneous Treatment of Saphenous Vein Bypass Graft Obstructions: A Continuing Obstinate Problem Circulation, May 13, 2003; 107(18): 2284 - 2286. [Full Text] [PDF]

				M. Roffi, D. Mukherjee, D. P. Chew, D. L. Bhatt, L. Cho, M. A. Robbins, K. M. Ziada, D. M. Brennan, S. G. Ellis, and E. J. Topol Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials Circulation, December 10, 2002; 106(24): 3063 - 3067. [Abstract] [Full Text] [PDF]

				G. W. Stone, C. Rogers, S. Ramee, C. White, R. E. Kuntz, J. J. Popma, J. George, S. Almany, and S. Bailey Distal filter protection during saphenous vein graft stenting: Technical and clinical correlates of efficacy J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1882 - 1888. [Abstract] [Full Text] [PDF]

				M.G Bourassa, K.M Detre, J.M Johnston, H.A Vlachos, and R Holubkov Effect of prior revascularization on outcome following percutaneous coronary intervention. NHLBI Dynamic Registry Eur. Heart J., October 1, 2002; 23(19): 1546 - 1555. [Abstract] [Full Text] [PDF]

				K. Tsunemi, S. Takai, M. Nishimoto, A. Yuda, D. Jin, M. Sakaguchi, Y. Sawada, K. Asada, K. Kondo, S. Sasaki, et al. Lengthy suppression of vascular proliferation by a chymase inhibitor in dog grafted veins J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 621 - 625. [Full Text] [PDF]

				R. Waksman, A. E. Ajani, R. L. White, R. C. Chan, L. F. Satler, K. M. Kent, A. D. Pichard, E. E. Pinnow, A. B. Bui, S. Ramee, et al. Intravascular Gamma Radiation for In-Stent Restenosis in Saphenous-Vein Bypass Grafts N. Engl. J. Med., April 18, 2002; 346(16): 1194 - 1199. [Abstract] [Full Text] [PDF]

				D. S. Baim, D. Wahr, B. George, M. B. Leon, J. Greenberg, D. E. Cutlip, U. Kaya, J. J. Popma, K. K.L. Ho, and R. E. Kuntz Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts Circulation, March 19, 2002; 105(11): 1285 - 1290. [Abstract] [Full Text] [PDF]

				E. C. Keeley, C. A. Velez, W. W. O'Neill, and R. D. Safian Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts J. Am. Coll. Cardiol., September 1, 2001; 38(3): 659 - 665. [Abstract] [Full Text] [PDF]

				M. K. Hong, R. Mehran, G. Dangas, G. S. Mintz, A. Lansky, K. M. Kent, A. D. Pichard, L. F. Satler, G. W. Stone, and M. B. Leon Are we making progress with percutaneous saphenous vein graft treatment?: A comparison of 1990 to 1994 and 1995 to 1998 results J. Am. Coll. Cardiol., July 1, 2001; 38(1): 150 - 154. [Abstract] [Full Text] [PDF]

				S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]

				U E Heidland, M P Heintzen, C J Michel, and B E Strauer Risk factors for the development of restenosis following stent implantation of venous bypass grafts Heart, March 1, 2001; 85(3): 312 - 317. [Abstract] [Full Text]

				J. Al Suwaidi, P. B. Berger, and D. R. Holmes Jr Coronary Artery Stents JAMA, October 11, 2000; 284(14): 1828 - 1836. [Abstract] [Full Text] [PDF]

				J. M. Ahmed, M. K. Hong, R. Mehran, G. Dangas, G. S. Mintz, A. D. Pichard, L. F. Satler, K. M. Kent, H. Wu, G. W. Stone, et al. Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1186 - 1193. [Abstract] [Full Text] [PDF]

				P.J. de Feyter The fatal attraction of saphenous venous bypass grafts Eur. Heart J., May 1, 2000; 21(9): 697 - 698. [PDF]

				J. M. Ahmed, M. K. Hong, R. Mehran, G. S. Mintz, A. J. Lansky, A. D. Pichard, L. F. Satler, K. M. Kent, H. Wu, G. W. Stone, et al. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1560 - 1568. [Abstract] [Full Text] [PDF]

				B. Bhargava, R. Kornowski, R. Mehran, K. M. Kent, M. K. Hong, A. J. Lansky, R. Waksman, A. D. Pichard, L. F. Satler, and M. B. Leon Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting J. Am. Coll. Cardiol., February 1, 2000; 35(2): 389 - 397. [Abstract] [Full Text] [PDF]

				C. Indolfi, A. Cioppa, E. Stabile, E. Di Lorenzo, G. Esposito, A. Pisani, A. Leccia, L. Cavuto, A. M. Stingone, A. Chieffo, et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury J. Am. Coll. Cardiol., January 1, 2000; 35(1): 214 - 221. [Abstract] [Full Text] [PDF]

				P. Sergeant, E. Blackstone, B. Meyns, B. Stockman, and R. Jashari First cardiological or cardiosurgical reintervention for ischemic heart disease after primary coronary artery bypass grafting Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 480 - 487. [Abstract] [Full Text] [PDF]

				K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]

				H.-z. Bai, Y. Sawa, W.-d. Zhang, T. Yamakawa, R. Morishita, Y. Kaneda, and H. Matsuda Gene transfer to vein graft wall by HVJ-liposome method: time course and localization of gene expression Ann. Thorac. Surg., September 1, 1998; 66(3): 814 - 819. [Abstract] [Full Text] [PDF]

				M. P. Savage, J. S. Douglas, D. L. Fischman, C. J. Pepine, S. B. King, J. A. Werner, S. R. Bailey, P. A. Overlie, S. H. Fenton, J. A. Brinker, et al. Stent Placement Compared with Balloon Angioplasty for Obstructed Coronary Bypass Grafts N. Engl. J. Med., September 11, 1997; 337(11): 740 - 747. [Abstract] [Full Text] [PDF]

				S. J. Brener, F. D. Loop, B. W. Lytle, S. G. Ellis, D. M. Cosgrove, and E. J. Topol A PROFILE OF CANDIDATES FOR REPEAT MYOCARDIAL REVASCULARIZATION: IMPLICATIONS FOR SELECTION OF TREATMENT J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 153 - 161. [Abstract] [Full Text]

				E. A. Tovar, N. Blau, A. Borsari, D. W. Landa, and J. M. Packer Severe Deformity of a Palmaz-Schatz Stent After Normal Surgical Manipulation Ann. Thorac. Surg., January 1, 1997; 63(1): 220 - 221. [Abstract] [Full Text]

				J. Lefkovits, D. R. Holmes, R. M. Califf, R. D. Safian, K. Pieper, G. Keeler, E. J. Topol, and f. t. C.-I. Investigators Predictors and Sequelae of Distal Embolization During Saphenous Vein Graft Intervention From the CAVEAT-II Trial Circulation, August 15, 1995; 92(4): 734 - 740. [Abstract] [Full Text]

				B. H. Strauss, M. K. Natarajan, W. B. Batchelor, D. E. Yardley, J. A. Bittl, T. A. Sanborn, J. A. Power, L. E. Watson, R. Moothart, J. E. Tcheng, et al. Early and Late Quantitative Angiographic Results of Vein Graft Lesions Treated by Excimer Laser With Adjunctive Balloon Angioplasty Circulation, August 1, 1995; 92(3): 348 - 356. [Abstract] [Full Text]

				D. R. Holmes Jr, E. J. Topol, R. M. Califf, L. G. Berdan, F. Leya, P. B. Berger, P. L. Whitlow, R. D. Safian, A. G. Adelman, M. A. Kellett Jr, et al. A Multicenter, Randomized Trial of Coronary Angioplasty Versus Directional Atherectomy for Patients With Saphenous Vein Bypass Graft Lesions Circulation, April 1, 1995; 91(7): 1966 - 1974. [Abstract] [Full Text]

				S. C. Wong, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, G. S. Mintz, Y. C. Chuang, M. K. Hong, C. J. Ditrano, and M. B. Leon Comparison of Clinical and Angiographic Outcomes After Saphenous Vein Graft Angioplasty Using Coronary Versus `Biliary' Tubular Slotted Stents Circulation, January 15, 1995; 91(2): 339 - 350. [Abstract] [Full Text]

				C. Landau, R. A. Lange, and L. D. Hillis Percutaneous Transluminal Coronary Angioplasty N. Engl. J. Med., April 7, 1994; 330(14): 981 - 993. [Full Text]